Go back to the main page.
Transforming Today's Science Into Tomorrow's Cures
Samaritan's collaborative researchers have made important patented discoveries in the fields of, central nervous system diseases, such as, Alzheimer's disease; cancer; cardiovascular disease; and infectious diseases, such as, AIDS, and Hepatitis C. These discoveries have positioned us with a rich pipeline of new drugs with novel mechanisms of actions to develop.
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics. At Samaritan Pharmaceuticals our mission has been to create life-saving drugs for people suffering from AIDS, Alzheimer’s, heart disease and cancer. View all the latest press releases and news articles focused on Samaritan Pharmaceuticals, Inc. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Samaritan has collaborative relationships with other pharmaceutical companies to commercialize branded approved prescription products in selected niche territories, such as, in Greece, Albania, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, FYROM, Hungary, Montenegro, Poland, Romania, Serbia, Slovakia, Slovania, Syria and Turkey. Before a drug can be offered to the public it must go through several phases of rigorous testing to make sure it is safe, efficient and does what it says it can do. The testing is mandated and overseen by the U.S. Food and Drug Administration (FDA) which is part of the U.S. Department of Health and Human Services. SAMARITAN PIPELINE - (MECHANISM OF ACTION VIDEOS)
Go back to the main page. Contact Samaritan Pharmaceuticals, Inc. Find what you are looking for in our website.

PARTNERING WITH SAMARITAN

Samaritan Pharmaceuticals is committed to developing therapies to improve the quality of life of patients. As such, we believe partnering with corporations and institutions who share this commitment is critical to developing products that make a difference to improving patients' lives. We are continually evaluating licensing and partnership opportunities. To discuss the in- or out-licensing opportunities please contact us at partnering@SamaritanPharma.com.
BUSINESS DEVELOPMENT

Kristi Eads, J.D.
V.P. Business Development / Out-Licensing
USA

tel: 702.735.7001
fax: 702.737.7016

View Bio | e-mail Kristi

Yannis S. Kalantzakis
Managing Director of Samaritan Pharmaceuticals Europe S.A.
EUROPE

11 Fillopapou Street
11741 - Athens Greece
tel: +302109237890
fax:+302109237892

View Bio | e-mail Yannis

Partnering
Opportunities